MELBOURNE, Australia, June 11, 2026 /PRNewswire/ -- Lateral Pharma today announced the publication of peer-reviewed research in PAIN, a leading journal dedicated to pain research, identifying Lanthionine Synthetase C-Like Protein 1 (LanCL1) as a novel therapeutic target for neuropathic...
Hence then, the article about peer reviewed publication shows that lateral pharma s scp drugs for neuropathic pain act via the novel target lancl1 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Peer-reviewed publication shows that Lateral pharma's SCP drugs for neuropathic pain act via the novel target LanCL1 )
Also on site :
- Warner Bros. Uses AI Dog Podcast to Promote ‘The End of Oak Street’: ‘Ewan McGregor Was Excellent With Treats’
- 1970 Song, Written About Eric Clapton's Unrequited Love for Best Friend's Wife, Took Years to Become a Hit
- Gina Prince-Bythewood Discusses the Worldbuilding of ‘Children of Blood and Bone’ and Praises Author Tomi Adeyemi as a ‘Genius’